Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Mehdi Farokhnia

National Institutes of Health

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

LinkedIn ORCID Google Scholar

Research Interests

Pharmacology

100%

Pharmacotherapy

70%

Alcohol Use

90%

Substance Abuse

80%

Neuropharmacology

60%

Alcohol Studies

40%

Addiction Neuroscience

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles25

Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake

Article Link

Year:

2025

Cocaine craving and use during pharmacotherapy trials for cocaine use disorder: A multi-trajectory analysis

Article Link

Year:

2025

Crosstalk between alcohol use disorder and obesity: two sides of the same coin?

Article Link

Year:

2025

An exploratory analysis of the relationship between ultraprocessed food consumption, alcohol intake, body composition, and cardiometabolic markers in individuals with alcohol use disorder

Article Link

Year:

2025

Bariatric surgery and alcohol and substance use: A case-control survey study

Article Link

Year:

2025

Global overview of short-term alcohol policies: need for global exchange of experience and impact measurement

Article Link

Year:

2025

Alcohol consumption and childhood trauma impact serum immunoglobulin levels in patients with alcohol use disorder

Article Link

Year:

2025

Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder

Article Link

Year:

2024

Spirituality and behavioural addictions: narrative review

Article Link

Year:

2024

Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials

Article Link

Year:

2024

Amylin in Alcohol Addiction: A Potential New Treatment Target or an Adjuvant to Other Treatments?

Article Link

Year:

2024

Lifetime use of alcohol and cannabis among U.S. adolescents across age: Exploring differential patterns by sex and race/ethnicity using the 2019 NSDUH data

Article Link

Year:

2024

A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder

Article Link

Year:

2024

The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission

Article Link

Year:

2023

Initial pharmacological characterization of a major hydroxy metabolite of PF-5190457: inverse agonist activity of PF-6870961 at the ghrelin receptor

Article Link

Year:

2023

GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

Article Link

Year:

2023

Relationship between self-stigma about alcohol dependence and severity of alcohol drinking and craving

Article Link

Year:

2023

Role of the ghrelin system in alcohol use disorder and alcohol‐associated liver disease: A narrative review

Article Link

Year:

2022

Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies

Article Link

Year:

2022

The glucagon‐like peptide‐1 system is modulated by acute and chronic alcohol exposure: Findings from human laboratory experiments and a post‐mortem brain study

Article Link

Year:

2022

The Mineralocorticoid Receptor: An Emerging Pharmacotherapeutic Target for Alcohol Use Disorder?

Article Link

Year:

2022

Blood Biomarkers of Alcohol Use: A Scoping Review

Article Link

Year:

2021

Effectiveness of spironolactone dispensation in reducing weekly alcohol use: a retrospective high-dimensional propensity score-matched cohort study

Article Link

Year:

2021

Effect of intravenous ghrelin administration, combined with alcohol, on circulating metabolome in heavy drinking individuals with alcohol use disorder

Article Link

Year:

2021

A population-based investigation of the association between alcohol intake and serum total ghrelin concentrations among cigarette-smoking, non-alcohol-dependent male individuals

Article Link

Year:

2021

Collaborators15

Amy Justice

Professor

Yale University School of Medicine

UNITED STATES

Lorenzo Leggio

UNITED STATES

James Hougland

Professor

Syracuse University

UNITED STATES

Sophia Khom

Assistant Professor

Universität Wien

AUSTRIA

Anthony P. Goldstone

UNITED KINGDOM

Laura Orsolini

Assistant Professor

Marche Polytechnic University

ITALY

William Simmons

Associate Professor

Oklahoma State University

UNITED STATES

Christopher Rentsch

Adjunct Assistant Professor

Yale University School of Medicine

UNITED STATES

Joseph Schacht

Associate Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

Kusum K. Kharbanda

University of Nebraska Medical Center

UNITED STATES

Vincent Lo Re

UNITED STATES

Claire Pince

University of Colorado Boulder

UNITED STATES

Elisabet Jerlhag

institute of neuroscience and physiology the sahlgrenska academy at the university of gothenburg gothenburg sweden

SWEDEN

Christian Hendershot

Associate Professor

University of North Carolina

UNITED STATES

Anders Fink-Jensen

Professor

DENMARK

How do I reach out?

Meet Kite AI